Your browser doesn't support javascript.
loading
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
McGregor, Bradley Alexander; Campbell, Matthew T; Xie, Wanling; Farah, Subrina; Bilen, Mehmet A; Schmidt, Andrew L; Sonpavde, Guru P; Kilbridge, Kerry L; Choudhury, Atish D; Mortazavi, Amir; Shah, Amishi Y; Venkatesan, Aradhana M; Bubley, Glenn J; Siefker-Radtke, Arlene O; McKay, Rana R; Choueiri, Toni K.
Afiliación
  • McGregor BA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Campbell MT; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Xie W; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Farah S; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Schmidt AL; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sonpavde GP; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kilbridge KL; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Choudhury AD; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mortazavi A; The Ohio State University, Columbus, Ohio.
  • Shah AY; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Venkatesan AM; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bubley GJ; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Siefker-Radtke AO; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • McKay RR; University of California San Diego, San Diego, California.
  • Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer ; 127(6): 840-849, 2021 03 15.
Article en En | MEDLINE | ID: mdl-33216356

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Urogenitales / Ipilimumab / Nivolumab Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Urogenitales / Ipilimumab / Nivolumab Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article